Trial Profile
Clinical Pharmacology Study of 5 mg , 10 mg, 20 mg and 40 mg Tablets of E3810 in Healthy Adult Japanese Male
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary)
- Indications Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Zollinger-Ellison syndrome
- Focus Pharmacodynamics
- Sponsors Eisai Co Ltd
- 29 Mar 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 22 Sep 2010 New trial record